Asian Neurostimulation/Neuromodulation Devices Market
- Report Code: NE 1000
- Publish Date: Upcoming
The Internal Neuromodulation market is estimated to register a CAGR of 13.8% during the forecast period. Rise in the incidences and prevalence of neurological diseases, rapid growth in aging population, development of advanced neurostimulation technologies, and increasing awareness are some of the key factors that are fueling the growth of the neuromodulation technologies market. However, lack of skilled professionals and unfavorable reimbursement scenario are some of the key challenges faced by the market players.
The emerging markets including China and India have become the key growth segments for the companies engaged in the development and marketing of the Internal Neuromodulation implants. Rising incidences of neurological disorders and government initiatives to increasing awareness by education campaigns are the key factors propelling the demand of neurological devices and technologies in the emerging markets.
Medtronic, Inc. (U.S.) held the leading position in the Asia-Pacific Internal Neuromodulation market. In recent years, the company has adopted expansion of its R&D capabilities, new product launches, and geographical expansion as its key business strategies to ensure its dominant position in this market. St. Jude Medical Inc. (U.S.) and Boston Scientific Inc. (U.S.) are some other key players competing in the Asia-Pacific Internal Neuromodulation market.
Scope of the Report
This research report categorizes the Asia-Pacific Internal Neuromodulation market into the following segments and subsegments:
Asia-Pacific Internal Neuromodulation Market, by Modality
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neurostimulator
Asia-Pacific Internal Neuromodulation Market, by Application
Spinal Cord Stimulator
Chronic Pain
Failed back surgery syndrome
Ischemic Pain
Others
Deep Brain Stimulator
Parkinson's Disease
Tremor
Depression
Others (Chronic Pain, Dystonia, Tourette's Syndrome, Alzheimer's)
Sacral Nerve Stimulator
Urinary Incontinence
Fecal Incontinence
Vagus Nerve Stimulator
Epilepsy
Others
Gastric Neurostimulator
Gastropareisis
Asia-Pacific Internal Neuromodulation Market, by Geography
Asia-Pacific
o China
o Japan
o India
o Republic of Korea
o Rest of Asia-Pacific
1 Introduction
1.1 Introduce the Market
1.2 Objective of the study
1.3 Market Definition and Scope of the study
1.3.1 Market Definition
1.3.2 Areas covered
1.3.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Secondary sources
1.5.2 Primary Sources
1.5.3 Market estimation methodology (Top-down, bottom-up, data triangulation.)
1.5.4 Macro indicators for the study
1.6 Assumptions
1.7 List of Acronyms
2 Market Overview
3 Neurostimulation/Neuromodulation Asia, By SurgeryProcedures
3.1 Split By Geography
3.2 Neurostimulation/Neuromodulation Asia-Neuromodulation Surgery
3.2.1 Asia-Neuromodulation Surgery, By Geographies
3.2.1.1 Asia - Japan-Neuromodulation Surgery
3.2.1.2 China-Neuromodulation Surgery
3.2.1.3 India-Neuromodulation Surgery
3.3 Neurostimulation/Neuromodulation Asia-Nerve Grafting
3.3.1 Asia-Nerve Grafting, By Geographies
3.3.1.1 Asia - Japan-Nerve Grafting
3.3.1.2 China-Nerve Grafting
3.3.1.3 India-Nerve Grafting
3.3.2 Asia-Nerve Grafting, By SurgeryProcedures
3.3.2.1 Asia-Autograft
3.3.2.2 Asia-Allograft
3.3.2.3 Asia-Xenograft
3.4 Asia-Direct Nerve Repair
3.4.1 Neurostimulation/Neuromodulation Asia-Direct Nerve Repair, By Geographies
3.4.1.1 Asia - Japan-Direct Nerve Repair
3.4.1.2 China-Direct Nerve Repair
3.4.1.3 India-Direct Nerve Repair
3.4.2 Asia-Direct Nerve Repair, By SurgeryProcedures
3.4.2.1 Asia-Group Fascicular Nerve Repair Surgery
3.4.2.2 Asia-Perineural Nerve Repair Surgery
3.4.2.3 Asia-Epineural Nerve Repair Surgery
3.5 Asia-Stem cell therapy
3.5.1 Asia-Stem cell therapy, By Geographies
3.5.1.1 Neurostimulation/Neuromodulation Asia - Japan-Stem cell therapy
3.5.1.2 China-Stem cell therapy
3.5.1.3 India-Stem cell therapy
4 Asia, By Types
4.1 Split By Geography
4.2 Internal Neurostimulation Asia
4.2.1 Internal Neurostimulation-Asia, By MacroIndicators
4.2.1.1 Internal Neurostimulation-Healthcare Expenditure-Asia
4.2.2 Internal Neurostimulation-Asia, By Companies
4.2.2.1 Internal Neurostimulation-Asia-Medtronic, Inc.
4.2.2.2 Internal Neurostimulation-Asia-Other Companies
4.2.2.3 Internal Neurostimulation-Asia-St. Jude Medical, Inc.
4.2.2.4 Internal Neurostimulation-Asia-Boston Scientific
4.2.2.5 Internal Neurostimulation-Asia-Cyberonics
4.2.2.6 Internal Neurostimulation-Asia-Johnson & Johnson
4.2.2.7 Internal Neurostimulation-Asia-Biocontrol Medical
4.2.2.8 Internal Neurostimulation-Asia-Greatbatch Inc
4.2.3 Internal Neurostimulation-Asia, By Geographies
4.2.3.1 Internal Neurostimulation-Asia - Japan
4.2.3.2 Internal Neurostimulation-China
4.2.3.3 Internal Neurostimulation-India
4.2.3.4 Internal Neurostimulation-Asia - Other Geographies
4.2.4 Internal Neurostimulation-Asia, By Types
4.2.4.1 Spinal cord stimulator-Asia
4.2.4.2 Deep Brain Stimulator-Asia
4.2.4.3 Sacral Nerve Stimulator-Asia
4.2.4.4 Vagus Nerve Stimulator-Asia
4.2.4.5 Gastric Electrical stimulator-Asia
4.3 External Neurostimulation Asia
4.3.1 External Neurostimulation-Asia, By Geographies
4.3.1.1 External Neurostimulation-Asia - Japan
4.3.1.2 External Neurostimulation-China
4.3.1.3 External Neurostimulation-India
4.3.2 External Neurostimulation-Asia, By Types
4.3.2.1 Transcutaneous Electrical Nerve Stimulation-Asia
4.3.2.2 Transcranial Magnetic Stimulation-Asia
5 Neurostimulation/Neuromodulation Asia, By Geographies
5.1 Neurostimulation/Neuromodulation Asia - Japan
5.1.1 Asia - Japan, By Companies
5.1.1.1 Asia - Japan-Medtronic, Inc.
5.1.1.2 Asia - Japan-Other Companies
5.1.1.3 Asia - Japan-St. Jude Medical, Inc.
5.1.1.4 Asia - Japan-Boston Scientific
5.1.1.5 Asia - Japan-Johnson & Johnson
5.1.1.6 Asia - Japan-Cyberonics
5.1.1.7 Asia - Japan-Biocontrol Medical
5.1.1.8 Asia - Japan-Greatbatch Inc
5.1.2 Asia - Japan, By SurgeryProcedures
5.1.2.1 Asia - Japan-Direct Nerve Repair
5.1.2.2 Asia - Japan-Nerve Grafting
5.1.2.3 Asia - Japan-Neuromodulation Surgery
5.1.2.4 Asia - Japan-Stem cell therapy
5.1.3 Asia - Japan, By Types
5.1.3.1 Internal Neurostimulation-Asia - Japan
5.1.3.2 External Neurostimulation-Asia - Japan
5.2 Neurostimulation/Neuromodulation China
5.2.1 China, By Companies
5.2.1.1 China-Medtronic, Inc.
5.2.1.2 China-Other Companies
5.2.1.3 China-St. Jude Medical, Inc.
5.2.1.4 China-Boston Scientific
5.2.1.5 China-Johnson & Johnson
5.2.1.6 China-Cyberonics
5.2.1.7 China-Biocontrol Medical
5.2.1.8 China-Greatbatch Inc
5.2.2 China, By SurgeryProcedures
5.2.2.1 China-Direct Nerve Repair
5.2.2.2 China-Nerve Grafting
5.2.2.3 China-Neuromodulation Surgery
5.2.2.4 China-Stem cell therapy
5.2.3 China, By Types
5.2.3.1 Internal Neurostimulation-China
5.2.3.2 External Neurostimulation-China
5.3 Neurostimulation/Neuromodulation India
5.3.1 India, By Companies
5.3.1.1 India-Medtronic, Inc.
5.3.1.2 India-Other Companies
5.3.1.3 India-St. Jude Medical, Inc.
5.3.1.4 India-Boston Scientific
5.3.1.5 India-Cyberonics
5.3.1.6 India-Biocontrol Medical
5.3.1.7 India-Johnson & Johnson
5.3.1.8 India-Greatbatch Inc
5.3.2 India, By SurgeryProcedures
5.3.2.1 India-Neuromodulation Surgery
5.3.2.2 India-Nerve Grafting
5.3.2.3 India-Direct Nerve Repair
5.3.2.4 India-Stem cell therapy
5.3.3 India, By Types
5.3.3.1 Internal Neurostimulation-India
5.3.3.2 External Neurostimulation-India
5.4 Neurostimulation/Neuromodulation Asia - Other Geographies
5.4.1 Asia - Other Geographies, By Types
5.4.1.1 Internal Neurostimulation-Asia - Other Geographies
6 Neurostimulation/Neuromodulation Asia, By Companies
6.1 Split By Geography
6.2 Neurostimulation/Neuromodulation Medtronic, Inc.-Asia
6.2.1 Medtronic, Inc.-Asia, By Types
6.2.1.1 Internal Neurostimulation-Asia-Medtronic, Inc.
6.3 Neurostimulation/Neuromodulation Asia-Other Companies
6.3.1 Asia-Other Companies, By Geographies
6.3.1.1 Asia - Japan-Other Companies
6.3.1.2 China-Other Companies
6.3.1.3 India-Other Companies
6.3.2 Asia-Other Companies, By Types
6.3.2.1 Internal Neurostimulation-Asia-Other Companies
6.4 Neurostimulation/Neuromodulation St. Jude Medical, Inc.-Asia
6.4.1 St. Jude Medical, Inc.-Asia, By Types
6.4.1.1 Internal Neurostimulation-Asia-St. Jude Medical, Inc.
6.5 Neurostimulation/Neuromodulation Boston Scientific-Asia
6.5.1 Boston Scientific-Asia, By Types
6.5.1.1 Internal Neurostimulation-Asia-Boston Scientific
6.6 Neurostimulation/Neuromodulation Johnson & Johnson-Asia
6.6.1 Johnson & Johnson-Asia, By Types
6.6.1.1 Internal Neurostimulation-Asia-Johnson & Johnson
6.7 Neurostimulation/Neuromodulation Asia-Greatbatch Inc
6.7.1 Asia-Greatbatch Inc, By Geographies
6.7.1.1 Asia - Japan-Greatbatch Inc
6.7.1.2 China-Greatbatch Inc
6.7.1.3 India-Greatbatch Inc
6.7.2 Asia-Greatbatch Inc, By Types
6.7.2.1 Internal Neurostimulation-Asia-Greatbatch Inc
6.8 Neurostimulation/Neuromodulation Asia-Cyberonics
6.8.1 Asia-Cyberonics, By Geographies
6.8.1.1 Asia - Japan-Cyberonics
6.8.1.2 China-Cyberonics
6.8.1.3 India-Cyberonics
6.8.2 Asia-Cyberonics, By Types
6.8.2.1 Internal Neurostimulation-Asia-Cyberonics
6.9 Neurostimulation/Neuromodulation Asia-Biocontrol Medical
6.9.1 Asia-Biocontrol Medical, By Geographies
6.9.1.1 Asia - Japan-Biocontrol Medical
6.9.1.2 China-Biocontrol Medical
6.9.1.3 India-Biocontrol Medical
6.9.2 Asia-Biocontrol Medical, By Types
6.9.2.1 Internal Neurostimulation-Asia-Biocontrol Medical
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Nerve Repair & Regeneration Market The North American Nerve Repair and Regeneration market was pegged at $2841.03 million in 2013 and expected to be $4709.59 million by 2018, growing at a CAGR of 10.6%. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating The North American Nerve Repair and Regeneration market segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Apr 2015 |
|
|
European Nerve Repair & Regeneration Market The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. |
Apr 2015 |
|
|
Asian Nerve Repair & Regeneration Market The Asian Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Mar 2015 |
